Oracle adds Stephen Rusckowski to board; all 13 director nominees elected
Oracle's board unanimously elected Stephen Rusckowski as a director effective November 18, 2025, and increased the board to 14 seats. At the same day's annual meeting, stockholders elected all 13 director nominees, cast a majority of votes in favor of the advisory say-on-pay proposal, and ratified Ernst & Young LLP as auditor for fiscal 2026.
Key points
- Stephen Rusckowski, former CEO and President of Quest Diagnostics (2012 to 2022), elected to the board effective November 18, 2025
- Board size increased to 14; he will receive pro rata restricted stock units and standard non-employee director cash compensation
- Say-on-pay advisory vote: 1,922,942,188 shares for and 423,773,929 against
- Ernst & Young LLP ratified as auditor for fiscal year ending May 31, 2026, with 2,549,762,065 shares for and 63,419,255 against
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:16 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 21, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.